TDEs can carry immunosuppressive molecules such as PD-L1, TGFβ1, FasL, TRAIL, and NKG2D ligands which make them important mediators of tumor immune evasion and possible targets for immunotherapy [63,64,65,66,67]. The gene discussed is TNFSF10; the disease is neoplasm.